Valuation: Toho Holdings Co., Ltd.

Market Cap 260B 1.6B 1.4B 1.29B 1.19B 2.25B 154B 2.29B 15.44B 6.07B 75.38B 6.02B 5.88B P/E 2027 *
19.9x
P/E 2028 * 18.4x
Enterprise Value 260B 1.6B 1.4B 1.29B 1.19B 2.25B 154B 2.29B 15.44B 6.07B 75.38B 6.02B 5.88B EV / Sales 2027 *
0.16x
EV / Sales 2028 * 0.16x
Free-Float
76.61%
Yield 2027 *
4.48%
Yield 2028 * 4.04%
06-30 GNI Group Ltd. completed the acquisition of AYUMI Pharmaceutical Corporation from Blackstone Inc. (NYSE:BX), Toho Holdings Co., Ltd. and Hisamitsu Pharmaceutical Co., Inc. CI
06-17 3D Investment Partners Pte. Ltd. Urges Shareholders of Toho Holdings Co., Ltd. CI
06-09 Toho Holdings Co., Ltd. Urging Shareholders to Vote Against Poison Pill Proposal CI
06-07 GNI to Acquire Ayumi Pharmaceutical in 44.8 Billion Yen Deal; Blackstone-Backed Fund Becomes Top Shareholder MT
06-04 GNI Group Ltd. agreed to acquire AYUMI Pharmaceutical Corporation from Blackstone Inc. (NYSE:BX), Toho Holdings Co., Ltd. and Hisamitsu Pharmaceutical Co., Inc. for ¥44.8 billion. CI
06-01 3D Investment Partners Urges Shareholders to Vote Against Toho HD?s Proposal 4 Poison Pill CI
05-13 Toho Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2026 CI
05-10 MP-2605 K.K. completed the acquisition of 53.42% stake in Solasto Corporation from Daito Trust Construction Co.,Ltd., Toho Holdings Co., Ltd., Goldman Sachs International, JPMorgan Securities Japan Co., Ltd., Medical Concierge Co., Ltd., The Master Trust Bank of Japan, Ltd., Custody Bank of Japan, Ltd. and others for ¥54.12 billion. CI
05-07 Japan's Listed Companies Face Investor Pressure on 20 Trillion Yen Real Estate Gains MT
04-30 Japan Shares Drop on Soft Output Data, Middle East Risks MT
04-29 Toho Holdings Flags Risks in 3D Investment Stake Build, Plans Vote on Proposed Acquisition MT
04-28 Toho Holdings Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ended March 31, 2026 CI
04-28 Toho Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026 CI
1 day+1.12%
1 week+2.55%
Current month+4.15%
1 month+4.28%
3 months-10.65%
6 months-13.76%
Current year-12.87%
1 week 3,938
Extreme 3938
4,148
1 month 3,729
Extreme 3729
4,148
Current year 3,729
Extreme 3729
5,031
1 year 3,729
Extreme 3729
5,726
3 years 2,655
Extreme 2655
5,726
5 years 1,678
Extreme 1678
5,726
10 years 1,653
Extreme 1653
5,726
Manager TitleAgeSince
Chief Executive Officer 74 2024-06-26
Director of Finance/CFO - -
Chief Operating Officer 61 2025-06-26
Director TitleAgeSince
Director/Board Member 60 2009-03-31
Director/Board Member 74 2015-05-31
Director/Board Member 61 2016-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.12%+2.55%-16.66%+50.83% 1.6B
+1.86%+5.89%+20.15%+107.30% 98.5B
+1.47%-1.68%+45.39%+148.03% 53.57B
-0.34%+3.90%+5.40%+283.01% 23.68B
+1.01%+6.04%-11.30%-19.20% 8.45B
+1.69%+10.93%-24.75%-28.77% 8.27B
-1.35%+5.02%-6.44%-27.10% 7.09B
+2.27%+0.75%+25.07%+34.59% 6.18B
+0.79%+3.00%+0.06%+26.02% 5.45B
+1.36%+4.60%-2.79%-3.62% 3.85B
Average +0.99%+2.91%+3.41%+57.11% 21.66B
Weighted average by Cap. +1.35%+2.61%+19.92%+115.54%

Financials

2027 *2028 *
Net sales 1,594B 9.81B 8.58B 7.93B 7.28B 13.77B 945B 14.01B 94.59B 37.16B 462B 36.85B 36.04B 1,630B 10.03B 8.77B 8.11B 7.44B 14.08B 967B 14.33B 96.72B 37.99B 472B 37.68B 36.85B
Net income 13.09B 80.58M 70.43M 65.14M 59.77M 113M 7.76B 115M 777M 305M 3.79B 303M 296M 14.28B 87.92M 76.85M 71.07M 65.22M 123M 8.47B 126M 848M 333M 4.14B 330M 323M
Net Debt - -
Logo Toho Holdings Co., Ltd.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
Employees
7,675
Date Price Change Volume
26-07-17 JP¥4,067.00 +1.12% 143,500
26-07-16 JP¥4,022.00 +0.35% 126,800
26-07-15 JP¥4,008.00 +0.65% 139,200
26-07-14 JP¥3,982.00 +0.30% 148,400
26-07-13 JP¥3,970.00 +0.10% 87,200
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
4,022.00JPY
Average target price
4,525.00JPY
Spread / Average Target
+12.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 8129 Stock